Diabetes mellitus associated with the use of protease inhibitors.

被引：0

作者：

Rodriguez-Rosado, R

Soriano, V

Jiménez-Nácher, I

Dona, C

Blanco, F

González-Lahoz, J

机构：

[1] Hosp Carlos III, Infect Dis Serv, Madrid, Spain

[2] Hosp Carlos III, Serv Pharm, Madrid, Spain

来源：

AIDS | 1998年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P150

引用

下载

页码：S54 / S54

页数：1

共 50 条

[11] Hyperlipidemia associated with the use of protease inhibitors
Smith, JH
Martin, GJ
Decker, CF
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 207 - 208
[12] Protease inhibitors associated with increased diabetes risk
Reactions Weekly, 2003, 950 (1) : 4 - 4
[13] Molecular modeling of HIV protease inhibitors.
Parish, C
Schram, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U224 - U224
[14] Molecular modeling of HIV protease inhibitors.
Lyons, T
Parish, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U267 - U267
[15] A predictive model for HIV protease inhibitors.
Ragno, R
Head, R
Marshall, GR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U693 - U693
[16] Molecular modeling of HIV protease inhibitors.
Parish, C
Lyons, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U503 - U503
[17] Glycine α-ketoamides as potent HCV protease inhibitors.
Han, W
Jiang, XJ
Hu, ZL
Wasserman, AR
Gorey-Feret, LJ
Meek, JL
Decicco, CP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U21 - U21
[18] Molecular simulations of novel HIV protease inhibitors.
Parish, C
James, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U224 - U224
[19] Molecular simulations of novel HIV protease inhibitors.
Goldberg, A
Parish, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U431 - U431
[20] Human antibodies as potent and selective protease inhibitors.
Nixon, A
Hoet, R
Kent, R
Rookey, K
Sato, AK
Hogan, S
Ladner, RC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U247 - U248

← 1 2 3 4 5 →